tiprankstipranks
Advertisement
Advertisement

MBRX Stock Latest News

Moleculin Biotech announces unblinded efficacy results from MIRACLE trial Part A
The FlyMoleculin Biotech announces unblinded efficacy results from MIRACLE trial Part A
10d ago
MBRX
Moleculin Biotech Updates Investors With New Presentation
PremiumCompany Announcements
Moleculin Biotech Updates Investors With New Presentation
10d ago
8K
MBRX
Moleculin Biotech Reports Promising Annamycin AML Trial Data
PremiumCompany Announcements
Moleculin Biotech Reports Promising Annamycin AML Trial Data
10d ago
8K
MBRX
Moleculin Highlights Strong Market Interest in Annamycin AML Therapy
PremiumCompany Announcements
Moleculin Highlights Strong Market Interest in Annamycin AML Therapy
1M ago
8K
MBRX
Moleculin Highlights Annamycin Cardiac Safety Data at ASCO
PremiumCompany Announcements
Moleculin Highlights Annamycin Cardiac Safety Data at ASCO
1M ago
8K
MBRX
Moleculin Biotech Releases Updated Investor Information Presentation
PremiumCompany AnnouncementsMoleculin Biotech Releases Updated Investor Information Presentation
2M ago
8K
MBRX
Moleculin Highlights Annamycin Cardiac Safety Data at ASCO
Premium
Company Announcements
Moleculin Highlights Annamycin Cardiac Safety Data at ASCO
2M ago
8K
MBRX
Buy Rating Reiterated on Moleculin Biotech as MIRACLE Trial Progress and Safety Profile Support Unchanged $22 Price Target
Premium
Ratings
Buy Rating Reiterated on Moleculin Biotech as MIRACLE Trial Progress and Safety Profile Support Unchanged $22 Price Target
2M ago
MBRX
Buy Rating Reiterated on Moleculin Biotech as MIRACLE Trial Progress Supports Unchanged $10 Price Target
PremiumRatings
Buy Rating Reiterated on Moleculin Biotech as MIRACLE Trial Progress Supports Unchanged $10 Price Target
2M ago
MBRX
Moleculin Biotech expects first unblinding of MIRACLE trial data by June 30
PremiumThe Fly
Moleculin Biotech expects first unblinding of MIRACLE trial data by June 30
2M ago
MBRX
Moleculin Nears First Unblinding in Pivotal MIRACLE Trial
PremiumCompany Announcements
Moleculin Nears First Unblinding in Pivotal MIRACLE Trial
2M ago
8K
MBRX
Moleculin announces publication on cardiac safety profiloe of annamycin
PremiumThe Fly
Moleculin announces publication on cardiac safety profiloe of annamycin
2M ago
MBRX
Moleculin highlights favorable cardiac safety data for Annamycin
PremiumCompany AnnouncementsMoleculin highlights favorable cardiac safety data for Annamycin
2M ago
8K
MBRX
Moleculin Biotech issued liposomal Annamycin patent in Hong Kong
Premium
The Fly
Moleculin Biotech issued liposomal Annamycin patent in Hong Kong
2M ago
MBRX
Moleculin Secures New Hong Kong Patent for Annamycin
Premium
Company Announcements
Moleculin Secures New Hong Kong Patent for Annamycin
2M ago
8K
MBRX
Moleculin Highlights Promising Preclinical Data for L-ANN
PremiumCompany Announcements
Moleculin Highlights Promising Preclinical Data for L-ANN
3M ago
8K
MBRX
Moleculin Biotech Stockholders Approve Warrant Share Issuance
PremiumCompany Announcements
Moleculin Biotech Stockholders Approve Warrant Share Issuance
3M ago
8K
MBRX
Moleculin Biotech management to meet with Maxim
PremiumThe Fly
Moleculin Biotech management to meet with Maxim
3M ago
MBRX
Moleculin Biotech files to sell 6.37M shares of common stock for holders
PremiumThe Fly
Moleculin Biotech files to sell 6.37M shares of common stock for holders
3M ago
MBRX
Moleculin Biotech announces enrollment milestone in MIRACLE trial
PremiumThe FlyMoleculin Biotech announces enrollment milestone in MIRACLE trial
4M ago
MBRX
Moleculin Advances MIRACLE Trial, Prepares Interim AML Readout
Premium
Company Announcements
Moleculin Advances MIRACLE Trial, Prepares Interim AML Readout
4M ago
8K
MBRX
Moleculin Biotech: Attractive Risk/Reward Ahead of Pivotal Annamycin Phase 3 Readout Supports Buy Rating and $10 Target
Premium
Ratings
Moleculin Biotech: Attractive Risk/Reward Ahead of Pivotal Annamycin Phase 3 Readout Supports Buy Rating and $10 Target
4M ago
MBRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >